MedPath

A multi-centre interventional study to determine patient and clinician impression of different compression therapy options for the treatment of poor leg circulatio

Not Applicable
Completed
Conditions
Venous insufficiency (chronic)(peripheral)
Chronic Venous Insufficiency
Circulatory System
Registration Number
ISRCTN95282887
Lead Sponsor
Cumbria Partnership NHS Foundation Trust
Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32501761/ (added 08/06/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
44
Inclusion Criteria

1. Clinical indication to commence, or already started, compression bandaging of the leg. This may due to venous leg ulcer or other qualifying reason. This will be equivalent to a CEAP classification score of C2 or higher (clinical element only – see Appendix 5)
2. ABPI > 0.5, measured within last 12 months. If not yet measured as part of routine clinical care, patients are allowed to be recruited into the trial and ABPI will then be measured. If the measurement is too low, the patient will be withdrawn from the study
3. Adult patients aged > 18 years
4. Mental capacity to give consent

Exclusion Criteria

1. Under the age of 18 years
2. Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity
3. Limited life expectancy, i.e. undergoing palliative care
4. Active infection in the leg, incl infected venous leg ulcer, cellulitis or otherwise, that requires systematic antibiotic treatment – or within 1 one week of completing antibiotics course. This includes prophylactic antibiotic use
5. Patients who are participating in another research study involving an investigational product that is related to leg, skin, or a co-morbidity that may influence the function of compression bandaging
6. The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise patient safety or study objectives
7. Ankle brachial index < 0.5, measured within 12 months of baseline visit or at baseline of trial participation
8. Any condition that is contraindicated for the use of any of the compression bandaging used in this trial (including ZnO, Calamine)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath